Computational and experimental methods for classifying variants of unknown clinical significance

Area of Science:

• Genomics
• Bioinformatics
• Clinical Medicine

Background:

• Next-generation sequencing (NGS) is increasingly used in patient care, driving the growth of human genetics and genomic medicine.
• The goal of precision medicine is to enable individualized treatments and preventive strategies through genomic data integration.
• Interpreting genetic variants, especially variants of uncertain clinical significance (VUSs), remains a significant challenge in clinical applications.

Purpose of the Study:

• To discuss the integration of computational and experimental methods for cataloging genetic variant effects.
• To explore the potential of combining large-scale functional data with machine learning and clinical knowledge.
• To improve the accuracy of pathogenicity predictions for clinical applications.

Main Methods:

• Utilizing computational tools for prioritizing genetic variants.
• Employing an expanding array of experimental methods to assess the molecular effects of VUSs.
• Integrating large-scale functional data, machine learning, and clinical knowledge.

Main Results:

• The study highlights the necessity of both computational and experimental approaches for variant interpretation.
• The development of comprehensive catalogs of variant effects across various phenotypes is discussed.
• The potential for enhanced pathogenicity prediction through integrated data analysis is explored.

Conclusions:

• Computational and experimental methods are essential for understanding genetic variant impacts.
• Integrating diverse data sources can lead to more accurate predictions of variant pathogenicity.
• This approach holds promise for advancing precision medicine and clinical decision-making.